Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeo Ohba

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Cancer Science|May 20, 2016
World Health Organization grade II-III astrocytomas consist of genetically distinct tumor lineagesNatsuki Hattori, Yuichi Hirose, Hikaru Sasaki, et al.
Journal of Computer Assisted Tomography|May 15, 2023
Three-Dimensional Gradient-Echo-Based Amide Proton Transfer-Weighted Imaging of Brain Tumors: Comparison With Two-Dimensional Spin-Echo-Based Amide Proton Transfer-Weighted ImagingKazuhiro Murayama, Yoshiharu Ohno, Masao Yui, et al.
Cancers|February 11, 2023
Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System LymphomaShigeo Ohba, Kazuhiro Murayama, Takao Teranishi, et al.
Science Translational Medicine|May 6, 2021
RETRACTED: A subset of PARP inhibitors induces lethal telomere fusion in ALT-dependent tumor cellsJoydeep Mukherjee, Ajay Pandita, Chatla Kamalakar, et al.
Frontiers in Human Neuroscience|August 1, 2025
Evaluation of higher cognitive functions following posterior quadrant disconnection in the non-dominant hemisphere: a Case ReportNoeru Kawase, Shunsuke Nakae, Masanobu Kumon, et al.
Journal of Computer Assisted Tomography|April 24, 2026
Automated Quantitative Analysis of Enhancing and Peritumoral Cerebral Blood Volume for Differentiating Glioblastoma From Central Nervous System LymphomaKazuhiro Murayama, Shohei Harada, Shigeo Ohba, et al.
Journal of Neuro-Oncology|November 13, 2016
Prediction of genetic subgroups in adult supra tentorial gliomas by pre- and intraoperative parametersShunsuke Nakae, Kazuhiro Murayama, Hikaru Sasaki, et al.
Neurologia Medico-Chirurgica|June 3, 2021
Myoinositol to Total Choline Ratio in Glioblastomas as a Potential Prognostic Factor in Preoperative Magnetic Resonance SpectroscopyMasanobu Kumon, Shunsuke Nakae, Kazuhiro Murayama, et al.
Acta Neuropathologica Communications|November 29, 2025
Targeting distinct amino acid metabolic vulnerabilities in IDH-mutant and IDH-wildtype gliomasShigeo Ohba, Akiyoshi Hirayama, Takao Teranishi, et al.
Clinical Neurology and Neurosurgery|March 6, 2026
Pazopanib for recurrent central nervous system solitary fibrous tumors: A single-institution retrospective seriesDaijiro Kojima, Shigeo Ohba, Yuya Nishiyama, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Cancer Science|May 20, 2016
World Health Organization grade II-III astrocytomas consist of genetically distinct tumor lineagesNatsuki Hattori, Yuichi Hirose, Hikaru Sasaki, et al.
Journal of Computer Assisted Tomography|May 15, 2023
Three-Dimensional Gradient-Echo-Based Amide Proton Transfer-Weighted Imaging of Brain Tumors: Comparison With Two-Dimensional Spin-Echo-Based Amide Proton Transfer-Weighted ImagingKazuhiro Murayama, Yoshiharu Ohno, Masao Yui, et al.
Cancers|February 11, 2023
Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System LymphomaShigeo Ohba, Kazuhiro Murayama, Takao Teranishi, et al.
Science Translational Medicine|May 6, 2021
RETRACTED: A subset of PARP inhibitors induces lethal telomere fusion in ALT-dependent tumor cellsJoydeep Mukherjee, Ajay Pandita, Chatla Kamalakar, et al.
Frontiers in Human Neuroscience|August 1, 2025
Evaluation of higher cognitive functions following posterior quadrant disconnection in the non-dominant hemisphere: a Case ReportNoeru Kawase, Shunsuke Nakae, Masanobu Kumon, et al.
Journal of Computer Assisted Tomography|April 24, 2026
Automated Quantitative Analysis of Enhancing and Peritumoral Cerebral Blood Volume for Differentiating Glioblastoma From Central Nervous System LymphomaKazuhiro Murayama, Shohei Harada, Shigeo Ohba, et al.
Journal of Neuro-Oncology|November 13, 2016
Prediction of genetic subgroups in adult supra tentorial gliomas by pre- and intraoperative parametersShunsuke Nakae, Kazuhiro Murayama, Hikaru Sasaki, et al.
Neurologia Medico-Chirurgica|June 3, 2021
Myoinositol to Total Choline Ratio in Glioblastomas as a Potential Prognostic Factor in Preoperative Magnetic Resonance SpectroscopyMasanobu Kumon, Shunsuke Nakae, Kazuhiro Murayama, et al.
Acta Neuropathologica Communications|November 29, 2025
Targeting distinct amino acid metabolic vulnerabilities in IDH-mutant and IDH-wildtype gliomasShigeo Ohba, Akiyoshi Hirayama, Takao Teranishi, et al.
Clinical Neurology and Neurosurgery|March 6, 2026
Pazopanib for recurrent central nervous system solitary fibrous tumors: A single-institution retrospective seriesDaijiro Kojima, Shigeo Ohba, Yuya Nishiyama, et al.
Pageof 10